Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: KINIKSA PHARMACEUTICALS (UK), LTD.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2024-05-28 to 2024-06-28
Current total value of award: $15902.63
Description: ARCALYST (RILONACEPT) 220 MG NDC: 73604-0914-04